Screener
United Therapeutics UTHR Total Revenue
Total Revenue at other companies
Segments
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: United Therapeutics’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 6:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001082554-26-000027
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total revenues | $783.3 | $798.6 | $1,564.8 | $1,593.0 |
| Operating expenses: | ||||
| Cost of sales | 99.5 | 87.6 | 232.9 | 180.1 |
| Research and development | 146.3 | 134.0 | 284.5 | 283.0 |
| Selling, general, and administrative | 206.7 | 212.5 | 390.8 | 382.6 |
| Total operating expenses | 452.5 | 434.1 | 908.2 | 845.7 |
| Operating income | 330.8 | 364.5 | 656.6 | 747.3 |
| Interest income | 31.5 | 51.3 | 73.3 | 102.4 |
Item 1. Consolidated Financial Statements
FAQ
- What is United Therapeutics's total revenue?
- United Therapeutics (UTHR) reported total revenue of $783.3M in Q2 2026.
- How has United Therapeutics's total revenue changed year-over-year?
- United Therapeutics's total revenue decreased by 1.9% year-over-year, from $798.6M to $783.3M.
- What is the long-term trend for United Therapeutics's total revenue?
- Over 4 years (2021 to 2025), United Therapeutics's total revenue has grown at a 17.2% compound annual growth rate (CAGR), from $1.69B to $3.18B.
- What does total revenue mean?
- The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.
Ask your AI about United Therapeutics's total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude